With Thursday’s 24 September deadline looming, international scientific societies and civil society leaders are pushing Spain to sponsor a last-minute nomination of Dr María Neira as World Health Organization (WHO) Director-General. Neira is WHO’s former Director for Environment, Climate Change and Health, and her nomination has been endorsed by Nobel Peace Prize Laureate Adolfo Pérez […] Continue reading ->
The race to lead the World Health Organization (WHO) is intensifying. Early digital campaign data reveals an active contest to capture the pivotal African vote and outreach to established United States, European Union and corporate networks. While the full field of contenders is still taking shape ahead of the formal nomination deadline, digital engagement metrics […] Continue reading ->
A new modelling study suggests that US Medicare “Most-Favored-Nation” policies on drug prices would cut Medicare spending on brand-name drugs, but potentially incentivize companies to increase prices or delay new drug launches elsewhere. Efforts to control the cost of government spending on drugs culminated in a Most-Favored-Nation (MFN) policy, a Trump administration initiative which ties […] Continue reading ->
Contracts, contracts, contracts. Virtually all the regional blocs that addressed the start of the eighth round of the pandemic agreement talks on Monday stressed that any pathogen access and benefit-sharing (PABS) system needs to include standard contracts with pharmaceutical manufacturers. These would set out the terms of accessing dangerous pathogens, as well as how to […] Continue reading ->
EU negotiator Americo Zampetti warns that ideological polarisation over pathogen access threatens to derail the WHO Pandemic Agreement. On the eve of the eighth round of talks on an annex to the Pandemic Agreement, the European Union’s (EU) chief negotiator has warned that “ideology” is blocking consensus. Negotiators meet at the Intergovernmental Working Group (IGWG) […] Continue reading ->